Interleukin-2 is a lymphokine with documented antineoplastic influence, with not completely understood mechanism of action. The case of 46-years old patient with relapsed metastatic malignant melanoma treated with constant-infusion of rIL-2 is described. 9-month remission was achieved. During the course of treatment a lot of side effects including flu-like symptoms, hypotonia, anemia and thrombocytopenia, and also many biochemical disturbances were observed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
malignant melanoma
8
[interleukin-2 treatment
4
treatment malignant
4
melanoma case
4
case report]
4
report] interleukin-2
4
interleukin-2 lymphokine
4
lymphokine documented
4
documented antineoplastic
4
antineoplastic influence
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!